Unknown

Dataset Information

0

Gs- versus Golf-dependent functional selectivity mediated by the dopamine D1 receptor.


ABSTRACT: The two highly homologous subtypes of stimulatory G proteins G?s (Gs) and G?olf (Golf) display contrasting expression patterns in the brain. Golf is predominant in the striatum, while Gs is predominant in the cortex. Yet, little is known about their functional distinctions. The dopamine D1 receptor (D1R) couples to Gs/olf and is highly expressed in cortical and striatal areas, making it an important therapeutic target for neuropsychiatric disorders. Using novel drug screening methods that allow analysis of specific G-protein subtype coupling, we found that, relative to dopamine, dihydrexidine and N-propyl-apomorphine behave as full D1R agonists when coupled to Gs, but as partial D1R agonists when coupled to Golf. The Gs/Golf-dependent biased agonism by dihydrexidine was consistently observed at the levels of cellular signaling, neuronal function, and behavior. Our findings of Gs/Golf-dependent functional selectivity in D1R ligands open a new avenue for the treatment of cortex-specific or striatum-specific neuropsychiatric dysfunction.

SUBMITTER: Yano H 

PROVIDER: S-EPMC5799184 | biostudies-literature | 2018 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Gs- versus Golf-dependent functional selectivity mediated by the dopamine D<sub>1</sub> receptor.

Yano Hideaki H   Cai Ning-Sheng NS   Xu Min M   Verma Ravi Kumar RK   Rea William W   Hoffman Alexander F AF   Shi Lei L   Javitch Jonathan A JA   Bonci Antonello A   Ferré Sergi S  

Nature communications 20180205 1


The two highly homologous subtypes of stimulatory G proteins Gαs (Gs) and Gαolf (Golf) display contrasting expression patterns in the brain. Golf is predominant in the striatum, while Gs is predominant in the cortex. Yet, little is known about their functional distinctions. The dopamine D<sub>1</sub> receptor (D1R) couples to Gs/olf and is highly expressed in cortical and striatal areas, making it an important therapeutic target for neuropsychiatric disorders. Using novel drug screening methods  ...[more]

Similar Datasets

| S-EPMC7067653 | biostudies-literature
| S-EPMC5800406 | biostudies-literature
| S-EPMC4627803 | biostudies-literature
| S-EPMC8584964 | biostudies-literature
| S-EPMC3443605 | biostudies-literature
| S-EPMC8369611 | biostudies-literature
| S-EPMC4460444 | biostudies-literature
| S-EPMC3362898 | biostudies-literature
| S-EPMC8204328 | biostudies-literature
| S-EPMC4850582 | biostudies-other